Abstract
Introduction
Cisplatin is an antitumor drug widely used in the treatment of many malignant tumours [1, 2] . However, the drug's use is limited because of its side effects in normal tissues, mainly injury to the kidneys [3, 4] . The clinical characteristics of cisplatin-induced nephrotoxicity are renal wasting of sodium, calcium, magnesium and amino acids, and decreased glomerular Although reactive oxygen species (ROS) are regarded as a central key in cisplatin-induced nephrotoxicity [7] , the exact roles of free radicals and the mechanisms involved in cisplatin cytotoxicity in renal tubule cells are still not completely understood.
Mitochondria, as the sites of aerobic respiration, are the principal generators of ROS in the cell [8] . Several lines of evidence demonstrated that cisplatin accumulated in the mitochondria of renal cells, hampering mitochondrial bioenergetics, increasing the production of ROS, inhibiting the absorption of calcium in the mitochondria, and causing the release of pro-apoptotic factors which ultimately result in renal tubular cell death [9] . Mitochondrial ROS (mtROS) production is tightly regulated by a number of factors, such as mitochondrial membrane potential, metabolic state of mitochondria, and O 2 levels [10] . The mitochondrial H 2 O 2 of cytochrome c [11] . In addition to regulation of mtROS production, mammalian cells have cellular oxidation and to maintain redox homeostasis. The superoxide dismutas (SOD) family including SOD1 (Cu/Zn-SOD), SOD2 (MnSOD) and extracellular SOD3 (EC-SOD) converts superoxide to H 2 O 2 . Subsequently, H 2 O 2 including peroxiredoxins, glutathione peroxidise and catalase [12] .
are also present in the mitochondria and become mitochondrial transcription factors, which of MnSOD thereby reducing the capacity of the mitochondrial antioxidant defences. In examined.
In the present study, we have demonstrated that cisplatin dose dependently reduced cisplatin-induced oxidative stress and apoptosis by regulating the expression of MnSOD and in vivo and in vitro. 
Cell culture

EDTA (Invitrogen).
Experimental models of acute kidney injury Study protocols were reviewed and approved by the Institutional Animal Care and Use Committee at Nanjing Medical University, China. In brief, male mice of 8-10 weeks old were used for experiments. For cisplatin injury, mice were intraperitoneally injected with a single dose of cisplatin at 20mg/kg. treatment. All quantitative data were obtained from six mice per group with each mouse coming from a separate experiment.
Quantitative PCR
Carlsbad, CA, USA) according to the manufacturer's protocol. Reverse transcription was performed using
Western blots
Thirty micrograms of proteins from cells or kidney tissues from cortex extract were separated by and incubated with antibodies, followed by horseradish peroxidase-conjugated secondary antibodies. The
Transient transfection
manufacturer's protocol.
RNA interference
Assessment of ROS levels measured. In brief, after drug exposure, the cells were double-stained by DCFDA (10 
Measurement of malondialdehyde (MDA) concentration
substances as previously described [19] . Results are expressed as nanomoles per milligram of protein.
Statistical analysis
Data are expressed as the average ± SEM of the indicated number of experiments. Statistical analysis
Results
Effect of cisplatin on the expression of p53, p66shc and MnSOD in HK-2 cells
cisplatin. As expected, expression was repressed after treatment with three different doses of cisplatin ( Fig. 1A expression and decreased MnSOD expression ( Fig. 1C and 1D ).
downstream genes and mtROS including phosphorylation, acetylation, ubiquitylation, neddylation, sumoylation, and induced the expression of mouse double minute protein 2 (Mdm2), which acts as a key recovery from the severe tubular injury induced by cisplatin ( Fig. 9C and 9D ).
p53 inhibitor blocked cisplatin-induced oxidative stress and apoptosis in the kidney
renal tubular epithelial cells in vivo. As shown in Fig. apoptosis. Furthermore, malondialdehyde (MDA) levels, the indicator used to assess the prooxidative status in kidneys, were increased in cisplatin-treated mice, but were improved in Furthermore, in vivo studies with mice also revealed that administration of reduced cisplatin-induced oxidative stress and ischemia, sepsis, and administration of nephrotoxic agents [22] . The most representative doxorubicin. Cisplatin is used for the treatment of testicular and ovarian cancers, but leads to nephrotoxicity [23] . Cisplatin treatment damages the proximal tubules both in vivo and in vitro [24] . Multiple factors and pathways are involved in acute kidney injury resulting showed that cisplatin treatment increased mtROS production via the disrupted respiratory chain in porcine proximal tubular cells [31] . Consistently, our results also found that cisplatin triggers the opening of the mitochondrial permeability transition pore and induces apoptosis and/or necrosis [32] . Oxidative stress is imbalance between ROS generation and antioxidant system that scav and is essential for maintaining normal cell development and function. Several studies have cells [33] . More importantly, in cisplatin-induced renal cell injury, overexpression of MnSOD provides protection against cisplatin-mediated cytotoxicity in cultured renal epithelial cells [34] . Our data support these studies that MnSOD decreased after cispatin treatment both in vivo and in vitro, and superoxide and cell injury, suggesting poor antioxidant response was induced by cispatin and MnSOD acts as a survival strategy against cisplatin-induced tubular cell injury. production and cell injury. These data indicated another possibility that cisplatin-induced 
